Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Gene methylation biomarkers in sputum as a classifier for lung cancer risk.

Leng S, Wu G, Klinge DM, Thomas CL, Casas E, Picchi MA, Stidley CA, Lee SJ, Aisner S, Siegfried JM, Ramalingam S, Khuri FR, Karp DD, Belinsky SA.

Oncotarget. 2017 Jul 15;8(38):63978-63985. doi: 10.18632/oncotarget.19255. eCollection 2017 Sep 8.

2.

Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.

Leng S, Wu G, Collins LB, Thomas CL, Tellez CS, Jauregui AR, Picchi MA, Zhang X, Juri DE, Desai D, Amin SG, Crowell RE, Stidley CA, Liu Y, Swenberg JA, Lin Y, Wathelet MG, Gilliland FD, Belinsky SA.

Cancer Res. 2015 Aug 1;75(15):3108-17. doi: 10.1158/0008-5472.CAN-15-0243. Epub 2015 Jul 16.

3.

Satisfaction with Care of Patients on Hemodialysis.

Richardson MM, Paine SS, Grobert ME, Stidley CA, Gabbay E, Harford AM, Zager PG, Miskulin DC, Meyer KB.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1428-34. doi: 10.2215/CJN.11241114. Epub 2015 Jun 30.

4.

15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers.

Leng S, Liu Y, Weissfeld JL, Thomas CL, Han Y, Picchi MA, Edlund CK, Willink RP, Gaither Davis AL, Do KC, Nukui T, Zhang X, Burki EA, Van Den Berg D, Romkes M, Gauderman WJ, Crowell RE, Tesfaigzi Y, Stidley CA, Amos CI, Siegfried JM, Gilliland FD, Belinsky SA.

J Natl Cancer Inst. 2015 Feb 23;107(5). pii: djv035. doi: 10.1093/jnci/djv035.

5.

Integrated statistical and pathway approach to next-generation sequencing analysis: a family-based study of hypertension.

Edwards JS, Atlas SR, Wilson SM, Cooper CF, Luo L, Stidley CA.

BMC Proc. 2014 Jun 17;8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo):S104. doi: 10.1186/1753-6561-8-S1-S104. eCollection 2014.

6.

Native American ancestry affects the risk for gene methylation in the lungs of Hispanic smokers from New Mexico.

Leng S, Liu Y, Thomas CL, Gauderman WJ, Picchi MA, Bruse SE, Zhang X, Flores KG, Van Den Berg D, Stidley CA, Gilliland FD, Belinsky SA.

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1110-6. doi: 10.1164/rccm.201305-0925OC.

7.

DNA repair variants, indoor tanning, and risk of melanoma.

Torres SM, Luo L, Lilyquist J, Stidley CA, Flores K, White KA, Erdei E, Gonzales M, Paine S, Vogel RI, Lazovich D, Berwick M.

Pigment Cell Melanoma Res. 2013 Sep;26(5):677-84. doi: 10.1111/pcmr.12117. Epub 2013 Jun 3.

8.

Endometrial cancer and a family history of cancer.

Cook LS, Nelson HE, Stidley CA, Dong Y, Round PJ, Amankwah EK, Magliocco AM, Friedenreich CM.

Gynecol Oncol. 2013 Aug;130(2):334-9. doi: 10.1016/j.ygyno.2013.04.053. Epub 2013 Apr 28.

9.

Genetic variation in SIRT1 affects susceptibility of lung squamous cell carcinomas in former uranium miners from the Colorado plateau.

Leng S, Picchi MA, Liu Y, Thomas CL, Willis DG, Bernauer AM, Carr TG, Mabel PT, Han Y, Amos CI, Lin Y, Stidley CA, Gilliland FD, Jacobson MR, Belinsky SA.

Carcinogenesis. 2013 May;34(5):1044-50. doi: 10.1093/carcin/bgt024. Epub 2013 Jan 25. Erratum in: Carcinogenesis. 2013 Jul;34(7):1698.

10.

Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers.

Flores KG, Stidley CA, Mackey AJ, Picchi MA, Stabler SP, Siegfried JM, Byers T, Berwick M, Belinsky SA, Leng S.

Carcinogenesis. 2012 Aug;33(8):1542-7. doi: 10.1093/carcin/bgs194. Epub 2012 Jun 4.

11.

Defining a gene promoter methylation signature in sputum for lung cancer risk assessment.

Leng S, Do K, Yingling CM, Picchi MA, Wolf HJ, Kennedy TC, Feser WJ, Baron AE, Franklin WA, Brock MV, Herman JG, Baylin SB, Byers T, Stidley CA, Belinsky SA.

Clin Cancer Res. 2012 Jun 15;18(12):3387-95. doi: 10.1158/1078-0432.CCR-11-3049. Epub 2012 Apr 17.

12.

Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study.

Leng S, Stidley CA, Liu Y, Edlund CK, Willink RP, Han Y, Landi MT, Thun M, Picchi MA, Bruse SE, Crowell RE, Van Den Berg D, Caporaso NE, Amos CI, Siegfried JM, Tesfaigzi Y, Gilliland FD, Belinsky SA.

Cancer Res. 2012 Feb 1;72(3):707-15. doi: 10.1158/0008-5472.CAN-11-3194. Epub 2011 Dec 2.

13.

Discovery of common SNPs in the miR-205/200 family-regulated epithelial to mesenchymal transition pathway and their association with risk for non-small cell lung cancer.

Leng S, Bernauer AM, Zhai R, Tellez CS, Su L, Burki EA, Picchi MA, Stidley CA, Crowell RE, Christiani DC, Belinsky SA.

Int J Mol Epidemiol Genet. 2011;2(2):145-55. Epub 2011 Apr 1.

14.

The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.

Leng S, Bernauer AM, Hong C, Do KC, Yingling CM, Flores KG, Tessema M, Tellez CS, Willink RP, Burki EA, Picchi MA, Stidley CA, Prados MD, Costello JF, Gilliland FD, Crowell RE, Belinsky SA.

Clin Cancer Res. 2011 Apr 1;17(7):2014-23. doi: 10.1158/1078-0432.CCR-10-3026. Epub 2011 Feb 25.

15.

Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model.

Belinsky SA, Grimes MJ, Picchi MA, Mitchell HD, Stidley CA, Tesfaigzi Y, Channell MM, Liu Y, Casero RA Jr, Baylin SB, Reed MD, Tellez CS, March TH.

Cancer Res. 2011 Jan 15;71(2):454-62. doi: 10.1158/0008-5472.CAN-10-3184. Epub 2011 Jan 11.

16.

Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers.

Stidley CA, Picchi MA, Leng S, Willink R, Crowell RE, Flores KG, Kang H, Byers T, Gilliland FD, Belinsky SA.

Cancer Res. 2010 Jan 15;70(2):568-74. doi: 10.1158/0008-5472.CAN-09-3410. Epub 2010 Jan 12.

17.

Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model.

Lyon CM, Klinge DM, Do KC, Grimes MJ, Thomas CL, Damiani LA, March TH, Stidley CA, Belinsky SA.

Carcinogenesis. 2009 Dec;30(12):2095-9. doi: 10.1093/carcin/bgp260.

18.

Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers.

Tessema M, Yu YY, Stidley CA, Machida EO, Schuebel KE, Baylin SB, Belinsky SA.

Carcinogenesis. 2009 Jul;30(7):1132-8. doi: 10.1093/carcin/bgp114. Epub 2009 May 12.

19.

Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency.

Losa M, Scavini M, Gatti E, Rossini A, Madaschi S, Formenti I, Caumo A, Stidley CA, Lanzi R.

Thyroid. 2008 Dec;18(12):1249-54. doi: 10.1089/thy.2008.0266.

PMID:
19012473
20.

Difference in airflow obstruction between Hispanic and non-Hispanic White female smokers.

Sood A, Stidley CA, Picchi MA, Celedón JC, Gilliland F, Crowell RE, Belinsky SA, Tesfaigzi Y.

COPD. 2008 Oct;5(5):274-81. doi: 10.1080/15412550802363345.

21.

DNA methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer.

Belinsky SA, Schiller JH, Stidley CA.

Nutr Rev. 2008 Aug;66 Suppl 1:S24-6. doi: 10.1111/j.1753-4887.2008.00061.x. Review. No abstract available.

22.

Association between common genetic variation in Cockayne syndrome A and B genes and nucleotide excision repair capacity among smokers.

Leng S, Bernauer A, Stidley CA, Picchi MA, Sheng X, Frasco MA, Van Den Berg D, Gilliland FD, Crowell RE, Belinsky SA.

Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2062-9. doi: 10.1158/1055-9965.EPI-08-0308.

23.

Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers.

Leng S, Stidley CA, Bernauer AM, Picchi MA, Sheng X, Frasco MA, Van Den Berg D, Gilliland FD, Crowell RE, Belinsky SA.

Carcinogenesis. 2008 Jul;29(7):1380-5. doi: 10.1093/carcin/bgn121. Epub 2008 May 21.

24.

Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation.

Leng S, Stidley CA, Willink R, Bernauer A, Do K, Picchi MA, Sheng X, Frasco MA, Van Den Berg D, Gilliland FD, Zima C, Crowell RE, Belinsky SA.

Cancer Res. 2008 Apr 15;68(8):3049-56. doi: 10.1158/0008-5472.CAN-07-6344.

25.

Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25.

Tessema M, Willink R, Do K, Yu YY, Yu W, Machida EO, Brock M, Van Neste L, Stidley CA, Baylin SB, Belinsky SA.

Cancer Res. 2008 Mar 15;68(6):1707-14. doi: 10.1158/0008-5472.CAN-07-6325.

26.

Genotypes in matrix metalloproteinase 9 are a risk factor for COPD.

Tesfaigzi Y, Myers OB, Stidley CA, Schwalm K, Picchi M, Crowell RE, Gilliland FD, Belinsky SA.

Int J Chron Obstruct Pulmon Dis. 2006;1(3):267-78.

27.

The burden of chronic kidney disease among the Zuni Indians: the Zuni Kidney Project.

Scavini M, Stidley CA, Paine SS, Shah VO, Tentori F, Bobelu A, Welty TK, MacCluer JW, Zager PG.

Clin J Am Soc Nephrol. 2007 May;2(3):509-16. Epub 2007 Apr 18.

28.

Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?

Tentori F, Hunt WC, Rohrscheib M, Zhu M, Stidley CA, Servilla K, Miskulin D, Meyer KB, Bedrick EJ, Johnson HK, Zager PG.

J Am Soc Nephrol. 2007 Aug;18(8):2377-84. Epub 2007 Jul 18.

29.

Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.

Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, Johnson DH, Schiller JH.

Br J Cancer. 2007 Apr 23;96(8):1278-83. Epub 2007 Apr 3.

30.

Mortality risk among hemodialysis patients receiving different vitamin D analogs.

Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc.

Kidney Int. 2006 Nov;70(10):1858-65. Epub 2006 Oct 4.

31.

Changing relationship of blood pressure with mortality over time among hemodialysis patients.

Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S, Bedrick EJ, Meyer KB, Johnson HK, Zager PG; Medical Directors of Dialysis Clinic Inc.

J Am Soc Nephrol. 2006 Feb;17(2):513-20. Epub 2006 Jan 5.

32.

Genotypes in matrix metalloproteinase 9 are risk factors for chronic obstructive pulmonary disease.

Tesfaigzi Y, Myers OB, Stidley CA, Schwalm K, Picchi M, Crowell RE, Gilliland FD, Belinsky SA.

Exp Lung Res. 2005 Sep;31 Suppl 1:74-5. No abstract available.

PMID:
16395864
33.

Gene promoter methylation in plasma and sputum increases with lung cancer risk.

Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD, Stidley CA, Picchi MA.

Clin Cancer Res. 2005 Sep 15;11(18):6505-11.

34.

Kidney disease among the Zuni Indians: the Zuni Kidney Project.

Scavini M, Shah VO, Stidley CA, Tentori F, Paine SS, Harford AM, Narva AS, Kessler DS, Bobelu A, Albert CP, Bobelu J, Jamon E, Natachu K, Neha D, Welty TK, MacCluer JW, Zager PG.

Kidney Int Suppl. 2005 Aug;(97):S126-31.

35.

Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.

Belinsky SA, Klinge DM, Stidley CA, Issa JP, Herman JG, March TH, Baylin SB.

Cancer Res. 2003 Nov 1;63(21):7089-93.

36.

The Zuni kidney project: a collaborative approach to an epidemic of kidney disease.

Stidley CA, Shah VO, Scavini M, Narva AS, Kessler D, Bobelu A, MacCluer JW, Welty TK, Zager PG.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S139-43.

37.

Family history, Hispanic ethnicity, and prostate cancer risk.

Stone SN, Hoffman RM, Tollestrup K, Stidley CA, Witter JL, Gilliland FD.

Ethn Dis. 2003 Spring;13(2):233-9.

PMID:
12785421
38.

Prevalence of hematuria among Zuni Indians with and without diabetes: The Zuni kidney Project.

Tentori F, Stidley CA, Scavini M, Shah VO, Narva AS, Paine S, Bobelu A, Welty TK, Maccluer JW, Zager PG.

Am J Kidney Dis. 2003 Jun;41(6):1195-204.

PMID:
12776271
39.

Epidemic of diabetic and nondiabetic renal disease among the Zuni Indians: the Zuni Kidney Project.

Shah VO, Scavini M, Stidley CA, Tentori F, Welty TK, MacCluer JW, Narva AS, Bobelu A, Albert CP, Kessler DS, Harford AM, Wong CS, Harris AA, Paine S, Zager PG.

J Am Soc Nephrol. 2003 May;14(5):1320-9.

40.

Prevalence of diabetes is higher among female than male Zuni indians.

Scavini M, Stidley CA, Shah VO, Narva AS, Tentori F, Kessler DS, Bobelu A, Albert CP, Bobelu J, Jamon E, Natachu K, Neha D, Waikaniwa M, Welty TK, MacCluer JW, Zager PG.

Diabetes Care. 2003 Jan;26(1):55-60.

PMID:
12502658
41.

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.

Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.

Cancer Res. 2002 Apr 15;62(8):2370-7.

42.

A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease.

Stidley CA, Shah VO, Narva AS, Dalton D, MacCluer JW, Bobelu A, Scavini M, Welty TK, Zager PG.

Am J Kidney Dis. 2002 Feb;39(2):358-68.

PMID:
11840378
43.

The excess costs of breast cancer health care in Hispanic and non-Hispanic female members of a managed care organization.

Tollestrup K, Frost FJ, Stidley CA, Bedrick E, McMillan G, Kunde T, Petersen HV.

Breast Cancer Res Treat. 2001 Mar;66(1):25-31.

PMID:
11368407
44.

Mammography utilization after a benign breast biopsy among Hispanic and non-Hispanic women.

Stidley CA, Tollestrup K, Frost F, Bedrick EJ, Petersen HV.

Cancer. 2001 May 1;91(9):1716-23.

PMID:
11335896
45.

Reduced DNA-dependent protein kinase activity is associated with lung cancer.

Auckley DH, Crowell RE, Heaphy ER, Stidley CA, Lechner JF, Gilliland FD, Belinsky SA.

Carcinogenesis. 2001 May;22(5):723-7.

PMID:
11323390
46.

The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung.

Divine KK, Gilliland FD, Crowell RE, Stidley CA, Bocklage TJ, Cook DL, Belinsky SA.

Mutat Res. 2001 Jan 5;461(4):273-8.

PMID:
11104903
47.

Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study.

Brooks WM, Stidley CA, Petropoulos H, Jung RE, Weers DC, Friedman SD, Barlow MA, Sibbitt WL Jr, Yeo RA.

J Neurotrauma. 2000 Aug;17(8):629-40.

PMID:
10972240
48.

Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers.

Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, Waldron JA.

Am J Epidemiol. 2000 Aug 15;152(4):307-15.

PMID:
10968375
49.

Reproducibility of 1H-MRS in vivo.

Brooks WM, Friedman SD, Stidley CA.

Magn Reson Med. 1999 Jan;41(1):193-7.

50.

Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus.

Sabet A, Sibbitt WL Jr, Stidley CA, Danska J, Brooks WM.

Stroke. 1998 Nov;29(11):2254-60.

PMID:
9804631

Supplemental Content

Loading ...
Support Center